Atherosclerosis and Hyperlipidemia

Erin D Michos,

Paul M Ridker,

Lorenz Räber,

Steven E Nissen,

Dylan L Steen, Harriette Van Spall,

Paul M Ridker,

Steven E Nissen, Harriette Van Spall,

Jiaqian Xu , Michael D Shapiro ,

Marc P Allard-Ratick , Pratik Sandesara , Arshed A Quyyumi , et al

Leo Buckley , Ahmed Aldemerdash ,

Donald E Cutlip ,

Edward T Carreras , Donna M Polk ,

Heather Currie , Christine Williams ,

Sergio Fazio ,

Donald E Cutlip ,

Marc Sirol ,

Jiaqian Xu , Michael D Shapiro ,

Leo Buckley , Ahmed Aldemerdash ,

Marc P Allard-Ratick , Pratik Sandesara , Arshed A Quyyumi , et al

Kilmer S McCully ,

Mohit Gupta , Borut Jug , Matthew J Budoff ,

Sergio Fazio ,

Christopher M Kramer ,

Articles

Current Evidence and Future Directions of PCSK9 Inhibition

Jiaqian Xu

,

Michael D Shapiro

,

Published:

16 February 2021

Citation:

US Cardiology Review 2021;15:e01.

DOI:

https://doi.org/10.15420/usc.2020.17
  • Views: Views 2331
  • Downloads: Downloads 135

HDL Cholesterol and Adverse Outcomes

Marc P Allard-Ratick

,

Pratik Sandesara

,

Arshed A Quyyumi

,

Laurence S Sperling

,

Published:

12 March 2019

Citation:

US Cardiology Review 2019;13(1):49–53

DOI:

https://doi.org/10.15420/usc.2019.3.2
  • Views: Views 1519
  • Downloads: Downloads 18

Novel Treatments for Cardiovascular Disease

Leo Buckley

,

Ahmed Aldemerdash

,

Citation:

US Cardiology Review 2017;11(2):98–104.

DOI:

https://doi.org/10.15420/usc.2017:20:2
  • Views: Views 1674
  • Downloads: Downloads 6

Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized Duration of Therapy

Donald E Cutlip

,

Citation:

US Cardiology Review 2017;11(1):31–6

DOI:

https://doi.org/10.15420/usc.2017:7:2
  • Views: Views 4206
  • Downloads: Downloads 7